ArticleTrials2024

Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial.

Noll L Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.